Initial evaluation of a 290-μm diameter subcutaneous glucose sensor:: Glucose monitoring with a biocompatible, flexible-wire, enzyme-based amperometric microsensor in diabetic and nondiabetic humans

被引:21
作者
Ishikawa, M [1 ]
Schmidtke, DW [1 ]
Raskin, P [1 ]
Quinn, CAP [1 ]
机构
[1] Univ Texas, Dept Chem Engn, Austin, TX 78712 USA
关键词
D O I
10.1016/S1056-8727(98)00011-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Results of the initial clinical evaluation in 20 human subjects of a subcutaneously implanted microsensor-based amperometrically glycemia-monitoring system, carried out between April 1994 and June 1995, are reported. The system was based on the electrical connection ("wiring") of the reaction centers of glucose oxidase to a gold electrode and on elimination of the chemicals that interfere with glucose monitoring through their horseradish peroxidase-catalyzed oxidation by internally generated hydrogen peroxide. The sensor was finer than a 29-gauge needle and had no leachable components. Because of its high selectivity for glucose, the sensor output was virtually nil at zero glucose level. This enables prompt "one-point" in vivo calibration of the sensor with a single blood glucose sample. Microsensors were subcutaneously implanted in ten nondiabetic and ten insulin-dependent diabetes mellitus (IDDM) volunteers. All subjects underwent standard meal tests and intravenous glucose-tolerance tests (IVGTT) in addition to hourly plasma glucose measurements. The sensor signals were continuously recorded, and the glucose concentration estimates were derived by calibrating the sensor using a single blood sample (one-point calibration). Regression analysis revealed that the sensor-estimated glucose concentrations were linearly related to the plasma glucose concentrations (r(2) = 0.75) over a wide glucose concentration range (2-28 mmol/L) (sensor estimate = plasma * 0.96 + 0.26 mmol/L). The difference between the estimated and actual glucose concentration was -0.13 +/- 0.23 mmol/L [mean +/- 95% confidence interval (CI), n = 546], and 95% of the estimates fell in clinically acceptable zones of the Clarke error grid. The sensing delay time was 10.4 +/- 2.3 min as measured by the IVGTT. The subjects reported no discomfort associated with wearing the sensors. (Journal of Diabetes and Its Complications 12;6:295-301, 1998.) (C) 1998 Elsevier Science Inc.
引用
收藏
页码:295 / 301
页数:7
相关论文
共 35 条
[1]   DEVELOPMENT OF A WEARABLE GLUCOSE SENSOR - STUDIES IN HEALTHY-VOLUNTEERS AND IN DIABETIC-PATIENTS [J].
AALDERS, AL ;
SCHMIDT, FJ ;
SCHOONEN, AJM ;
BROEK, IR ;
MAESSEN, AGFM ;
DOORENBOS, H .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1991, 14 (02) :102-108
[2]  
ABEL P, 1989, Artificial Organs, V13, P170
[3]   APPLICATION OF CHRONIC INTRAVASCULAR BLOOD-GLUCOSE SENSOR IN DOGS [J].
ARMOUR, JC ;
LUCISANO, JY ;
MCKEAN, BD ;
GOUGH, DA .
DIABETES, 1990, 39 (12) :1519-1526
[4]   MICRODIALYSIS MEASUREMENT OF THE ABSOLUTE GLUCOSE-CONCENTRATION IN SUBCUTANEOUS ADIPOSE-TISSUE ALLOWING GLUCOSE MONITORING IN DIABETIC-PATIENTS [J].
BOLINDER, J ;
UNGERSTEDT, U ;
ARNER, P .
DIABETOLOGIA, 1992, 35 (12) :1177-1180
[5]   PROGRESS IN PRACTICAL ENDOCRINOLOGY - THE GLUCOSENSOR UNITEC ULM - A PORTABLE MONITOR FOR CONTINUOUS BLOOD-GLUCOSE MEASUREMENT [J].
BRUCKEL, J ;
ZIER, H ;
KERNER, W ;
PFEIFFER, EF .
HORMONE AND METABOLIC RESEARCH, 1990, 22 (07) :382-384
[6]   FERROCENE-MEDIATED ENZYME ELECTRODE FOR AMPEROMETRIC DETERMINATION OF GLUCOSE [J].
CASS, AEG ;
DAVIS, G ;
FRANCIS, GD ;
HILL, HAO ;
ASTON, WJ ;
HIGGINS, IJ ;
PLOTKIN, EV ;
SCOTT, LDL ;
TURNER, APF .
ANALYTICAL CHEMISTRY, 1984, 56 (04) :667-671
[7]   SUBCUTANEOUS IMPLANTATION OF A FERROCENE-MEDIATED GLUCOSE SENSOR IN PIGS [J].
CLAREMONT, DJ ;
SAMBROOK, IE ;
PENTON, C ;
PICKUP, JC .
DIABETOLOGIA, 1986, 29 (11) :817-821
[8]   EVALUATING CLINICAL ACCURACY OF SYSTEMS FOR SELF-MONITORING OF BLOOD-GLUCOSE [J].
CLARKE, WL ;
COX, D ;
GONDERFREDERICK, LA ;
CARTER, W ;
POHL, SL .
DIABETES CARE, 1987, 10 (05) :622-628
[9]  
CSOREGI E, 1994, ANAL CHEM, V66, P3131
[10]  
FISCHER U, 1989, ARTIF ORGANS, V13, P453